Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P10
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -203.09% |
| Q4 2025 | 161.39% |
| Q3 2025 | 75.69% |
| Q2 2025 | -139.39% |
| Q1 2025 | 515.67% |
| Q4 2024 | -44.51% |
| Q3 2024 | 1307.50% |
| Q2 2024 | 95.79% |
| Q1 2024 | -26.67% |
| Q4 2023 | 21.05% |
| Q3 2023 | 0.00% |
| Q2 2023 | -5.56% |
| Q1 2023 | -14900.00% |
| Q4 2022 | 94.92% |
| Q3 2022 | 8.88% |
| Q2 2022 | -144.43% |
| Q1 2022 | 183.01% |
| Q4 2021 | 260.94% |
| Q3 2021 | 64.35% |
| Q2 2021 | -150.07% |
| Q1 2021 | 71600.00% |
| Q4 2020 | -98.31% |
| Q3 2020 | 103.47% |
| Q2 2020 | -591.33% |
| Q1 2020 | 31.06% |
| Q4 2019 | 147.83% |
| Q3 2019 | -154.38% |
| Q2 2019 | 32.40% |
| Q1 2019 | -237.77% |
| Q4 2018 | -46.68% |
| Q3 2018 | 172.59% |
| Q2 2018 | -772.46% |
| Q1 2018 | 19.77% |
| Q4 2017 | 85.99% |
| Q3 2017 | 72.09% |
| Q2 2017 | -69.23% |
| Q1 2017 | -182.61% |
| Q4 2016 | 80.00% |
| Q3 2016 | 23.33% |
| Q2 2016 | -7.14% |